| Dr Anna Roshal, MD | |
|
150 Entrance Way, Saint Peters, MO 63376-1645 | |
| (636) 916-9920 | |
| (636) 916-9176 |
| Full Name | Dr Anna Roshal |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 27 Years |
| Location | 150 Entrance Way, Saint Peters, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124081799 | NPI | - | NPPES |
| ENROLLED | Medicaid | IL | |
| 207394602 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 2005028007 (Missouri) | Secondary |
| 207RX0202X | Internal Medicine - Medical Oncology | 01057442A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health North Hospital | Carmel, IN | Hospital |
| Iu Health West Hospital | Avon, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Indiana University Health Arnett Hospital | Lafayette, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Diagnostic Associates Inc | 3375446347 | 279 |
News Archive
Time-lapsed video of individual breast tissue cells reveals a never-before-seen event in the life of a cell: a protein that cycles between two major compartments in the cell. The results give researchers a more complete view of the internal signals that cause breast tissue cells to grow, events that go awry in cancer and are targets of drug development.
The New York Times reports that standards are being developed to protect consumers' choices of doctors and hospitals under the health law's new insurance plans. Also, the Wall Street Journal checks in on how the ranks of the uninsured are reacting to the overhaul.
Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.
Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).
A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has found that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes-insulin-producing beta cells.
› Verified 6 days ago
| Entity Name | University Medical Diagnostic Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861441537 PECOS PAC ID: 3375446347 Enrollment ID: O20040202000510 |
News Archive
Time-lapsed video of individual breast tissue cells reveals a never-before-seen event in the life of a cell: a protein that cycles between two major compartments in the cell. The results give researchers a more complete view of the internal signals that cause breast tissue cells to grow, events that go awry in cancer and are targets of drug development.
The New York Times reports that standards are being developed to protect consumers' choices of doctors and hospitals under the health law's new insurance plans. Also, the Wall Street Journal checks in on how the ranks of the uninsured are reacting to the overhaul.
Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.
Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).
A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has found that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes-insulin-producing beta cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna Roshal, MD 250 N Shadeland Ave Ste 200, Indianapolis, IN 46219-4959 Ph: () - | Dr Anna Roshal, MD 150 Entrance Way, Saint Peters, MO 63376-1645 Ph: (636) 916-9920 |
News Archive
Time-lapsed video of individual breast tissue cells reveals a never-before-seen event in the life of a cell: a protein that cycles between two major compartments in the cell. The results give researchers a more complete view of the internal signals that cause breast tissue cells to grow, events that go awry in cancer and are targets of drug development.
The New York Times reports that standards are being developed to protect consumers' choices of doctors and hospitals under the health law's new insurance plans. Also, the Wall Street Journal checks in on how the ranks of the uninsured are reacting to the overhaul.
Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.
Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).
A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has found that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes-insulin-producing beta cells.
› Verified 6 days ago
Furqan F Raja, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Circle, Suite 405, Saint Peters, MO 63376 Phone: 636-720-0310 Fax: 636-720-0311 | |
Dr. Pierre Moeser, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Cir, Ste 300, Saint Peters, MO 63376 Phone: 636-916-9020 Fax: 636-916-9021 | |
Dr. Ron Javdan, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 6 Jungermann Cir, Suite 203, Saint Peters, MO 63376 Phone: 636-928-1822 Fax: 636-441-7033 | |
Dr. Lawrence Osei, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Dept Anesthesiology, Saint Peters, MO 63376 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. Sandeep Hindupur, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr Ste 100, Saint Peters, MO 63376 Phone: 636-916-7272 | |
April Thebeau, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 314-317-0600 Fax: 314-317-0606 |